The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies

被引：57
|
作者：
Woelderink, A
Ibarreta, D
Hopkins, MM
Rodriguez-Cerezo, E
机构：
[1] European Commiss, Joint Res Ctr, IPTS, E-41092 Seville, Spain
[2] Univ Sussex, SPRU Sci & Technol Policy Res, Brighton, E Sussex, England
来源：
PHARMACOGENOMICS JOURNAL | 2006年 / 6卷 / 01期
基金：
英国经济与社会研究理事会;
关键词：
D O I：
10.1038/sj.tpj.6500341
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
[No abstract available]
引用
收藏
页码：3 / 7
页数：5
相关论文
共 50 条
  • [1] The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies
    A Woelderink
    D Ibarreta
    M M Hopkins
    E Rodriguez-Cerezo
    The Pharmacogenomics Journal, 2006, 6 : 3 - 7
  • [2] HER2 status in breast cancer -: an example of pharmacogenetic testing
    Kroese, Mark
    Zimmern, Ron L.
    Pinder, Sarah E.
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2007, 100 (07) : 326 - 329
  • [3] Current status of HER2 testing
    Di Leo, A
    Dowsett, M
    Horten, B
    Penault-Llorca, F
    ONCOLOGY, 2002, 63 : 25 - 32
  • [4] HER2: Closing the Gap Between Laboratory Testing and Clinical Practice
    Plebani, Mario
    Lippi, Giuseppe
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 131 (06) : 897 - 898
  • [5] HER2: Closing the Gap Between Laboratory Testing and Clinical Practice Reply
    Hicks, David G.
    Kulkarni, Swati
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 131 (06) : 899 - 900
  • [6] Fluorescence quantitative image analysis of HER2 evaluation against current clinical HER2 assays in breast cancer testing
    Kornaga, E. N.
    Feng, X.
    Klimowicz, A. C.
    Dean, M. L.
    Guggisberg, N.
    Morris, D. G.
    Magliocco, A. M.
    CANCER RESEARCH, 2016, 76
  • [7] HER2 testing: Current status and future directions
    Perez, Edith A.
    Cortes, Javier
    Gonzalez-Angulo, Ana Maria
    Bartlett, John M. S.
    CANCER TREATMENT REVIEWS, 2014, 40 (02) : 276 - 284
  • [8] Current technologies for HER2 testing in breast cancer
    Moelans, C. B.
    de Weger, R. A.
    Van der Wall, E.
    van Diest, P. J.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 80 (03) : 380 - 392
  • [9] Pharmacogenetic Panel Testing: A Review of Current Practice and Potential for Clinical Implementation
    Mosch, R.
    van der Lee, M.
    Guchelaar, H. J.
    Swen, J. J.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2025, 65 : 91 - 109
  • [10] HER2 testing for breast carcinoma: recommendations for rapid diagnostic pathways in clinical practice
    Shaaban, A. M.
    Purdie, C. A.
    Bartlett, J. M. S.
    Stein, R. C.
    Lane, S.
    Francis, A.
    Thompson, A. M.
    Pinder, S. E.
    JOURNAL OF CLINICAL PATHOLOGY, 2014, 67 (02) : 161 - 167
12345